$0.00
A CBS News investigation into the FDA reveals that the organization has approved a number of drugs despite objections from its own scientists. Among the questionably approved drugs was Rezulin, a diabetes drug, and Relenza, a flu drug. "The series exposed a serious rift between FDA rank-and-file scientists who felt their concerns were being ignored, and FDA executives who repeatedly sided with pharmaceutical companies over issues of safety regarding controversial drugs."
